True Wealth Design’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$1.08K 2808
2025
Q4
$1.08K Hold
15
﹤0.01% 1678
2025
Q3
$654 Buy
+15
New +$606 ﹤0.01% 1914

Other funds holding RNAM

True Wealth Design's RNAM Position: Q1 2026 in Review

True Wealth Design sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 15 shares — an estimated $1.08K sold.

True Wealth Design first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $1.08K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • True Wealth Design reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • True Wealth Design sold 15 Avidity Biosciences shares in Q1 2026, an estimated $1.08K.
  • True Wealth Design first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • True Wealth Design's Avidity Biosciences position peaked at $1.08K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on True Wealth Design's 13F filing for Q1 2026, filed 13 Apr 2026.